Stay updated on Disitamab Vedotin & Pembrolizumab in HER2+ Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Disitamab Vedotin & Pembrolizumab in HER2+ Urothelial Cancer Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FiBrykYpM757-eSs_QRXFH7kFo2Q.uncropped.jpg&w=3840&q=75)
Latest updates to the Disitamab Vedotin & Pembrolizumab in HER2+ Urothelial Cancer Clinical Trial page
- ChecktodayNo Change Detected
- CheckyesterdayNo Change Detected
- Check3 days agoChange DetectedNew content was added on July 24, 2024, following the deletion of previous content on July 16, 2024.SummaryDifference0.3%
- Check4 days agoChange DetectedThe website has been updated to version 2.10.0, introducing new features for viewing and comparing study record versions.SummaryDifference6%
- Check5 days agoNo Change Detected
- Check10 days agoChange DetectedThe website has been updated with new content as of July 16, 2024, while content from July 10, 2024, has been removed.SummaryDifference0.3%
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.3%
- Check16 days agoChange DetectedThe website has added new content dated July 10, 2024, while content from July 3, 2024, has been removed.SummaryDifference0.3%
- Check24 days agoChange DetectedThe value on the webpage has been updated from 2024-06-25 to 2024-07-03, indicating a recent change in the information being displayed.SummaryDifference0.7%
Stay in the know with updates to Disitamab Vedotin & Pembrolizumab in HER2+ Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Disitamab Vedotin & Pembrolizumab in HER2+ Urothelial Cancer Clinical Trial page.